Omid Veiseh

Omid Veiseh

Company: Avenge Bio

Job title: Co-Founder


Clinically translatable cytokine delivery platform for cancer immunotherapy 3:30 pm

Describe the development of the LOCOcyteTM, an allogeneic cell-based immunotherapy platform to enable potent localized modulation of the immune system which also precipitates a systemic immune response for cancer immunotherapy Highlight pre clinical data with our LOCOcyteTM platform demonstrating tumor eradication in advanced ovarian cancer, colorectal, and mesothelioma cancer mouse models. Review non human primate…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.